Newsom announces $50-million contract to make California’s own brand of insulin
LA TimesGavin Newsom announced a new $50-million contract with the nonprofit generic drugmaker Civica to produce insulin under the state’s own label during a news conference Saturday in Downey. California Health and Human Services Secretary Dr. Mark Ghaly said that under the deal, Civica would commit to delivering as much insulin as California needs under the CalRx label. He said “$50 million will go towards the development of low cost insulin products and an additional $50 million will go towards a California based insulin manufacturing facility.” With FDA approval, the contract announced Saturday is expected to deliver insulin to Californians starting in 2024, Newsom said. Rob Bonta said that Eli Lilly, Sanofi and Novo Nordisk are finding ways to “aggressively hike” the price of insulin at the expense of many patients.
History of this topic
California, drugmaker partner to produce affordable insulin
Associated Press
California Department of Justice suing pharmaceutical companies over high insulin costs
LA Times
California aims to make its own insulin brand to lower price
Associated Press
California aims to slash insulin prices and challenge Big Pharma. Can it succeed?
LA Times
After targeting Big Pharma, Newsom hasn’t delivered big savings on drug prices
LA TimesDiscover Related
